Neil Cashman
CIK 1927064 · View on SEC EDGAR ↗
First SEC filing: July 7, 2022 · Latest: July 7, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2025 | PMN | P | 15,000 | $0.97 | $14,550 | 16,617 Indirect | +927.64% | Acquired | -38.8% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | PMN | Option (right to buy) | Common Shares (50,000) | $10.77 | May 20, 2036 | 50,000 | Acquired |
| Feb. 3, 2026 | PMN | Warrants to purchase Common Shares | Common Shares (4,122) | $14.40 | Feb. 3, 2031 | 4,122 | Acquired |
| Nov. 18, 2024 | PMN | Option (right to buy) | Common Shares (200,000) | $1.00 | Nov. 18, 2034 | 200,000 | Acquired |
| Oct. 26, 2023 | PMN | Option (right to buy) | Common Shares (12,500) | $1.87 | Oct. 26, 2033 | 12,500 | Acquired |
| Aug. 23, 2023 | PMN | Warrants to purchase Common Shares | Common Shares (10,643) | $1.75 | Feb. 21, 2029 | 10,643 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 7, 2022 | PMN | Common Shares | 102,661 | Direct |
| July 7, 2022 | PMN | Common Shares | 1,617 | Indirect |
| July 7, 2022 | PMN | Option (right to buy)→ Common Shares (78,822) | 78,822 | Direct |
| July 7, 2022 | PMN | Option (right to buy)→ Common Shares (36,988) | 36,988 | Direct |
| July 7, 2022 | PMN | Option (right to buy)→ Common Shares (50,000) | 50,000 | Direct |
| July 7, 2022 | PMN | Warrants (right to buy)→ Common Shares (8,333) | 8,333 | Direct |
| July 7, 2022 | PMN | Warrants (right to buy)→ Common Shares (3,472) | 3,472 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
PMN
Chief Scientific Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $353,093 | — | — | — | — | — | — | $515,886 |
| 2023 | $359,657 | — | — | — | — | — | — | $378,822 |
| 2022 | $333,795 | — | — | — | — | — | — | $577,724 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.